ximately 15% of cases 5, 6 . In childhood, most affected age is four years of age, being approximately twice as common in Caucasian patients as compared to non-Caucasians 7, 8 . Studies show that oral manifestations such as pain, hyperplasia and gingival bleeding may be the first signs of leukemia patients 4, 9 . Treatment of choice for this cancer is chemotherapy, which may be used together with other therapies [10] [11] [12] . In the last four decades, there has been major progress in the treatment of leukemia and approximately 80% of children and teenagers with early diagnosis may be cured 8 . However, several studies point to anticancer treatment as inducing oral mucositis 1, 2, 4 . Oral mucositis is characterized by erythema, followed by very painful ulcers in oral mucosa, which interfere with nutritional status and quality of life (QL), and may limit or even interrupt anticancer therapy in severe cases 2 . Several studies indicate chlorhexidine gluconate, due to its antibacterial and antifungal activity and binding to tissue surfaces, to prevent and treat oral manifestations of such patients, especially mucositis 2, 13 . However, they caution that there may be sequelae for patients with long-term use of chlorhexidine, such as burning sensation, dysgeusia and dental pigmentation 13 . The understanding of oral injuries caused by acute leukemias (AL) and anticancer therapies is dentists' duty, as well as the use of prophylactic and therapeutic measures to promote patients' oral health and help the return of their physical wellbeing. In light of the above, this study aimed at carrying out a systematic analysis of articles published in the last 15 years with regard to the use of chlorhexidine to treat and prevent mucositis in AL children submitted to chemotherapy.
CONTENTS
A systematic search of articles published between January 2000 and January 2015 was carried out in Pubmed/Medline, Science Direct and LILACS databases, looking for studies evaluating the use of chlorhexidine to prevent and treat oral mucositis in AL patients. The following terms were used for the search: Acute Leukemia, Oral Mucositis, Chlorhexidine, Treatment, Prevention, Oral Mucosa, as well as their synonyms and corresponding words in Portuguese and Spanish, in different combinations. Boolean operators AND, OR, NOT were used. Search strategies are shown in table 1.
After getting the abstracts, three independent investigators have selected relevant studies according to inclusion and exclusion criteria. Inclusion criteria were original articles in English, Portuguese or Spanish, aiming at evaluating chlorhexidine to prevent and treat oral mucositis in AL patients; and articles published as of January 2000. Exclusion criteria were clinical cases, review articles, population outside research standards, articles published before 2000 or in different languages from those selected for the study. The first selection stage was to evaluate titles and abstracts. Then, all studies the titles or abstracts of which were considered relevant to the subject where obtained in whole and completely analyzed. At the end, articles analyzed and selected by evaluators after consensus meeting were included in this review. After initial search, 15 studies had potential to be included in this study, however after detailed and complete analysis, only 6 have met all methodological inclusion criteria [13] [14] [15] [16] [17] [18] . Among selected studies, 5 were performed in developing countries [13] [14] [15] 17, 18 and one in a developed country 16 . Methods and results of evaluated studies are shown in tables 2 and 3. Participants' sample among selected studies has varied from 14 to 48 patients, in a total of 160 participants. Four studies were performed primarily in children between 2 and 15 years of age 16, 17 . Most participants of the studies were above 15 years of age. Oral mucositis prevention and treatment with chlorhexidine gluconate were evaluated by 5 selected studies. Another study has evaluated chlorhexidine gluconate in children with ALL already with oral mucositis 18 . Intraoral exam was used to evaluate patients of selected studies. Studies 14, 16 have used microbiological tests. Pereira Pinto et al. 13 also used cytological exam. Aiming at evaluating pain level of patients, authors 16, 18 have used questionnaires applied to participants. Chlorhexidine gluconate concentration was 0.12%, except for the study by Mehdipour et al. 17 the concentration of which was 0.2%. Three studies had control group without treatment 13, 15, 17 . Choi & Kim 16 have compared chlorhexidine and sodium bicarbonate to treat oral mucositis and sodium bicarbonate has shown better results. In the study of Mehdipour et al. 17 , zinc sulfate was compared to chlorhexidine with better results in early evaluations of the study; however there has been no statistically significant difference in the final analysis of the experiment which has lasted 1 month. Setiawan, Reniarti & Oewen 18 , who analyzed the effi- Table 1 . Search strategies and number of articles found on databases Compare the effectiveness of chlorhexidine gluconate and povidoneiodine mouthwash for oral mucositis in children receiving chemotherapy for ALL.
ALL
18/ 2 to 10 years Children developing mucositis in the chemotherapy induction phase were evaluated. Group A received 0.12% chlorhexidine, group B povidone-iodine, group C saliva solution. Mouthwashes were performed twice a day (morning and evening) being the protocol repeated every day until injury remission or for a maximum period of two weeks.
Clinical oral mucosa exam.
Evaluate the effects of chlorhexidine gluconate and povidone-iodine on oral mucosa and compare both to control group. ALL = acute lymphoid leukemia; AML = acute myeloid leukemia.
cacy of chlorhexidine and povidone-iodine to treat mucositis, have observed that the chlorhexidine group had faster lesion remission as compared to the second group. With regard to oral mucosa site most affected by mucositis, only one study of Costa et al. 15 has reported this frequency, being jugal mucosa and lip the sites reported by the authors. Chemotherapeutic drugs used during patients' follow-up period are shown in table 4. Only the study by Soares et al. 14 has not informed the chemotherapeutic scheme used for anticancer therapy. Selected studies are unanimous in stating that the stage with most oral mucositis affections is during induction and that adequate oral hygiene is critical for preventing oral lesions.
DISCUSSION
Primary treatment of choice for acute leukemias is chemotherapy, with protocols lasting more than one year 19, 20 . This treatment is divided in phases which are induction, consolidation and maintenance. Maintenance phase is the longest treatment period and in which children have better clinical stability 19, 21 . Induction phase is considered by the literature the phase with highest incidence of oral mucositis. Three of selected studies for this review have used methotrexate in the induction phase 13, 15, 18 . Mucositis was more frequent between days 2 and 4 after beginning of treatment using intravenous methotrexate with mean remission times Zinc sulfate was better to control oral mucositis as compared to chlorhexidine in initial weeks, without statistically significant difference in the last exam.
Pereira Pinto et al. 13 Mucositis was observed in six group I and eight group II children and was characterized by the presence of edema, erythema and ulcers.
Not mentioned in the study.
Chlorhexidine was beneficial in decreasing oral manifestations in children.
S e t i a w a n , Reniartie Oewen 18 All children had oral mucositis in the beginning of the study.
The study showed that mucositis and related pain presented remission in 5 to 7 days for the chlorhexidine solution group, 8 to 14 days for the povidoneiodine group and 13 to 14 days for the control group. ALL = acute lymphoid leukemia. Under induction chemotherapy with idarubicin and enocitabine or LLA cyclophosphamide, vincristin and daunorubicin.
Mehdipour et al. 17 Citarabine in the induction phase and novantrone in the consolidation phase.
Pereira Pinto et al. 13 Protocol for acute leukemia treatment proposed by the Brazilian Society of Pediatric Oncology 16 . Methotrexate was a drug used in this therapy. 0.12% chlorhexidine gluconate was administered for 10 consecutive days, after each methotrexate infusion during intensification chemotherapy.
Setiawan, Reniartie Oewen 18 Methotrexate (one spinal dose in days 1, 14 and 42), Dexamethasone (one 6mg/m2/day oral dose during 5 weeks), vincristin (one 1.5mg/m2 intravenous dose in continuous infusion in 5 minutes in days 7, 14, 21, 28, 35) , and L-asparaginase (one 6000ug/m2 intravenous dose in weeks 4 and 5). MADIT = methotrexate, cytarabine and dexamethasone. of 16 days, being the severity of oral lesions and their duration in children receiving chlorhexidine mouthwashes shorter as compared to control group 15 . Similar results were found by other studies 13, 22, 23 . According to Setiawan, Reniarti & Oewen 18 , mucositis in general occurs between days 7 and 10 after beginning of treatment, especially in cases when methotrexate is used. Studies refer that the effectiveness of 0.12% chlorhexidine gluconate is probably related to its bactericide action. In the literature, mucositis is related to chemotherapy agents' dose, administration type and interval, and such factors may vary according to the protocol used. So, it is understood that different protocols of the selected studies might have influenced the higher or lower incidence of oral mucositis, as well as the severity of the process, which significantly impairs a more judicious analysis. In this review, all studies showed significant decrease in oral mucositis, as well as less severity and time of the disease with chlorhexidine digluconate, being its use indicated for prevention and treatment. However, previous studies show that only with accurate oral hygiene it would be possible to prevent oral mucositis in leukemia patients 22, 23 . It is known that poor oral cavity hygiene is another factor favoring local infections and, in addition, it is the entry point for systemic infections, impairing patients' general status and increasing their hospital stay. Adequate oral hygiene associated to prophylactic treatment of mucositis is paramount for the prevention of such oral lesion. According to these studies, it is understood that a good oral hygiene associated to chlorhexidine digluconate is able to decrease mucositis--induced pain in ALL children under anticancer treatment. Among selected studies, three have compared chlorhexidine to other therapies. Setiawan, Reniart & Oewen 18 have compared povidone-iodine to chlorhexidine, being that the latter had better results to treat oral mucositis, with remission of 5 to 7 days versus 8 to 14 days for povidone-iodine. However, povidone-iodine had better results as compared to the control group using saliva solutions, which is in line with other studies 24, 25 . For the author, better chlorhexidine result may be related to the fact that it is absorbed by oral surfaces and released in mouth for a period of 24h, thus being in contact with the oral cavity for a longer time. A study evaluating during four weeks chlorhexidine and zinc sulfate has observed better early results for zinc sulfate, however, in the fourth week, the difference between groups was not statistically significant. Zinc sulfate has positive effects on epithelization, is antioxidant and has antibacterial action, being effective for the maintenance of mucosal integrity and therapeutically acting during early mucositis stages 17 . Choie & Kim 16 had better results with sodium bicarbonate as compared to chlorhexidine; however, at microbiological analysis, the number of micro-organisms in the oral cavity of patients using sodium bicarbonate was higher than of those using chlorhexidine, being this result similar to other studies 26, 27 . According to the literature, the origin of oral mucosa lesions is directly related to anticancer treatment, being consequence of two major mechanisms: direct toxicity of the therapy on the mucosa and myelosuppression generated by the treatment 20 , and its course may be influenced by infection. Alkaline solutions, water associated to sodium bicarbonate, change oral cavity pH, inhibiting saliva acidity thus eliminating an environment prone to bacterial and fungal proliferation. In the study by Soares et al. 14 , microbiological analysis has shown the presence of a small number of potentially pathogenic micro-organisms. Patients with oral mucositis had higher frequency of coagulase-negative staphylococcus (80%) as compared to patients with normal oral mucosa (33.3%). Labarca et al. 28 point that the micro-organism associated to severe neutropenia may favor the onset of oral mucositis. There are few studies in the literature aiming at evaluating the direct relationship between a specific drug used in chemotherapy and the incidence of oral mucositis. It is known, however, that chemotherapy agents more commonly associated to the development of oral mucositis are 5-fluoracil, methotrexate 29 , cisplatin, bleomycin and doxorubicin 30 . Selected studies for this review have not established correlation between chemotherapy schemes and frequency of oral mucositis among participants. The study by Mehdipour et al.
